Sign in
SION Stock Price, Chart, Stats & News
Sionna Therapeutics, Inc.
Save
1.68B
Market cap
–
Current P/E
–
Forward P/E
SION chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -23.09% |
ROE | -22.87% |
D/E | 0.03x |
Interest coverage ratio | – |
SION valuation
P/E | – |
P/S | – |
P/B | 4.71x |
P/CF | -21.80x |
P/FCF | -24.40x |
P/OCF | -21.80x |
PEG | 3.07x |
EV multiple | -22.28x |
About
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis.
Similar securities
Based on sector and market capitalization
Report issue